SCA
CRL icon

Snowden Capital Advisors’s Charles River Laboratories CRL Stock Holding History

Snowden Capital Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Buy
+971
New +$173K 0.01% 1248
2025
Q3 		– Sell
-1,400
Closed -$212K – 1243
2025
Q2 		$212K Sell
1,400
-182
-12% -$24.3K 0.01% 1149
2025
Q1 		$238K Sell
1,582
-877
-36% -$147K 0.01% 1090
2024
Q4 		$454K Sell
2,459
-406
-14% -$78.2K 0.01% 811
2024
Q3 		$564K Buy
2,865
+954
+50% +$198K 0.02% 718
2024
Q2 		$395K Sell
1,911
-204
-10% -$46.2K 0.01% 862
2024
Q1 		$573K Sell
2,115
-219
-9% -$52.3K 0.02% 701
2023
Q4 		$552K Buy
2,334
+218
+10% +$42.9K 0.02% 659
2023
Q3 		$415K Sell
2,116
-169
-7% -$34.7K 0.02% 728
2023
Q2 		$480K Buy
2,285
+391
+21% +$77.8K 0.02% 755
2023
Q1 		$382K Buy
1,894
+239
+14% +$54.2K 0.01% 846
2022
Q4 		$361K Sell
1,655
-187
-10% -$40.8K 0.02% 852
2022
Q3 		$362K Buy
1,842
+136
+8% +$29.4K 0.02% 805
2022
Q2 		$365K Sell
1,706
-717
-30% -$175K 0.02% 775
2022
Q1 		$688K Buy
2,423
+2,062
+571% +$636K 0.03% 537
2021
Q4 		$136K Sell
361
-1,619
-82% -$629K 0.01% 759
2021
Q3 		$817K Buy
1,980
+178
+10% +$73.9K 0.04% 407
2021
Q2 		$667K Buy
+1,802
New +$602K 0.03% 461

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Snowden Capital Advisors's CRL Position: Q2 2026 in Review

Snowden Capital Advisors opened a new position in Charles River Laboratories (CRL) in Q2 2026: 971 shares worth $220K. The stake represents 0.01% of the portfolio and ranks #1248 among its holdings. This is a return to the name: Snowden Capital Advisors previously reported a position in CRL as recently as Q2 2025.

Snowden Capital Advisors first reported a position in CRL in Q2 2021 and has held it in 18 quarters since. The position peaked at $817K in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Snowden Capital Advisors held 971 shares of Charles River Laboratories worth $220K as of Q2 2026.
  • Charles River Laboratories was a new Snowden Capital Advisors position in Q2 2026.
  • Charles River Laboratories made up 0.01% of Snowden Capital Advisors's portfolio in Q2 2026, its #1248 holding.
  • Snowden Capital Advisors first reported a position in Charles River Laboratories in Q2 2021 and has held it in 18 quarters since.
  • Snowden Capital Advisors's Charles River Laboratories position peaked at $817K in Q3 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.